AstraZeneca COVID-19 Vaccine Efficacy and Blood Clots: Let’s Talk Data
April 26, 2021
AstraZeneca COVID-19 Vaccine Efficacy and Blood Clots: Let’s Talk Data
Authored By: Meng Zhu, Mohit Bhandari On Behalf of OrthoEvidence
To view the full content, login to your account,
FREE TRIAL LOGIN Forgot Password?SHARE THIS OE ORIGINAL
Loading...
Join the Conversation
Please Login or Join to leave comments.
Orthopaedic Surgeon - Australia
This all makes perfect sense However, I wish for your advice as how to counsel a patient in Australia who is vaccine hesitant Their risk of contracting COViD at present is negligible while Australia’s border policies remain as they are It is highly likely that a small number of those given AZ will become seriously ill and/or die as a result The only persuasive argument appears to be that widespread vaccination may allow the borders to open and avoid sudden lockdowns But it is very hard to argue that any individual will be less likely to become ill if they receive an AZ shot What would you say to them?